YKL-40 May Be a Promising Biomarker in GPP YKL-40 is emerging as a promising biomarker in psoriasis, particularly in severe and generalized forms such as GPP and psoriatic arthritis.

YKL-40, a chitinase-like glycoprotein involved in inflammation and tissue remodeling, is emerging as a promising biomarker in #Psoriasis, particularly in severe and generalized forms such as #GeneralizedPustularPsoriasis (GPP) and #PsoriaticArthritis.

Read more: https://bit.ly/47yW4hG

#YKL40 #GPP